Top honours awarded at MM2017

SHPA President Professor Michael Dooley with Dr Danielle Stowasser (left), Dr Michael Barras (upper right) and Dr Karen Whitfield (lower right) 
Three leading Australian pharmacists were presented with awards for excellence at Medicines Management 2017 between Friday 17 and Sunday 19 November.

Rounding out the first day on Friday 17 November, SHPA President Professor Michael Dooley announced Dr Danielle Stowasser as the recipient of the prestigious Fred J Boyd Award for 2017.
 
Welcoming Dr Stowasser onto the plenary stage at the 43rd SHPA National Conference in Sydney, Professor Dooley noted the ground-breaking impact of Dr Stowasser’s PhD thesis in establishing pre-admission clinical pharmacists and developing a system of medication delivery liaisons.
 
‘Danielle has led a range of initiatives to enhance safe and effective medicine use, including systems for reducing adverse drug events through standardised prescription and administration services.
 
‘This has been instrumental in improvements across Queensland – Danielle has been a wonderful contributor in implementing APAC guidelines, state wide pharmacy information management systems, and developing rural and remote support services in pharmacy departments across the state.’
 
Professor Dooley also acknowledged Dr Chris Alderman, Elizabeth Anderson and Karen O’Leary, who are worthy nominees for this prestigious award. 
 
‘Our 2017 nominees personify what the Fred J. Boyd Award was set up for: innovative pharmacists who care deeply about progressing and developing their field, and through that, benefitting Australia’s public.
 
‘We are extremely proud to have professionals of this calibre as members of our Society.’
 
Upon accepting the award, Dr Stowasser paid tribute to Dr John Youngman as a catalyst for change in Queensland, and called on others to step up to continue work on a national scale.
 
‘Nothing is possible without leadership and vision, and today I call on all current and future leaders of hospital pharmacy to continue moving pharmacy forward across four key areas.

‘These are: the endorsement of fully comprehensive meds management cycle, interoperability of medicines supply systems, robotics and automation as the Australian workforce ages and recognition of and training in pharmacy informatics. 
 
Dr Stowasser said this leadership could come from any corner of the profession.
 
‘It’s not about your title, it’s how you use it that makes a difference. I implore all of you to be leaders, no matter how big or small your goal.
 
‘And, just as importantly, invest in the next generation – mentoring can yield years of benefits for both parties.’
 
On the second day of the conference, Dr Michael Barras, a Fellow of SHPA, was announced as the recipient of the SHPA Medal of Merit, challenging all hospital pharmacists to sharpen their research skills to drive the profession forward.
 
In bestowing the award, SHPA President Professor Michael Dooley paid tribute to Dr Barras’ leadership and research focus over 25 years in the profession.
 
‘Michael has been recognised today for his wonderful contribution to mentoring and developing younger hospital pharmacists, and he has had an exceptional influence in research surrounding hospital pharmacy.
 
’This has been exemplified by a number of contributions including being the Convenor of the Research Grants Committee, as part of SHPA’s National Translational Research Committee, which aims to develop and foster a stronger culture of research collaboration and capability across Australia.’
 
Dr Barras is currently the Deputy Director of Clinical Pharmacy at the Princess Alexandra Hospital in Brisbane and a research conjoint at the University of Queensland School of Pharmacy. 
 
In accepting the medal, Dr Barras celebrated the scope and influence of hospital pharmacy practice and called for its evolution to continue.
 
‘I've always found it extremely attractive that we are able to influence patient outcomes and to do so in an interdisciplinary environment. We should all aspire to be the best possible clinicians, and I firmly believe to do this means having the skills to research.
 
‘It's in our genes to seek, discover, evaluate and advance patient care, and this can only be achieved by testing new ideas. I believe it's quite unethical to accept the status quo.’
 
Dr Barras described the experience as precious, and humbling.
 
‘When your peers acknowledge your contribution to the profession it is humbling, particularly considering the outstanding calibre and contributions of previous recipients, and I'm extremely proud to be a member of this esteemed group.
 
On Sunday 19 November, Dr Karen Whitfield was honoured for her contributions to hospital pharmacy, receiving the 2017 SHPA Australian Clinical Pharmacy Award.
 
In announcing the award on the closing day, SHPA President Professor Michael Dooley acknowledged the broad impact of Dr Whitfield’s significant contributions.
 
‘Dr Whitfield has been a member of the SHPA for almost 15 years, but her contributions to hospital pharmacy both in Australia and internationally span decades. 
 
‘Karen’s work in Women’s and Newborn’s Health has had a lasting impact on the way infants and women are treated nationwide.’
 
Professor Dooley acknowledged the excellent standard of nominees this year, singling out Luke Grzerkowiak (SA), Cindy Patterson (NSW) and Sonya Stacey (Qld) for special mention.
 
‘We had many very worthy pharmacists nominated for this year’s award, and I congratulate all of them on their many achievements and accolades in the field.’
 
Upon accepting the award, Dr Whitfield encouraging pharmacists to get inspired and involved in research, of any scale.
 
‘Even small studies can lead to big changes in clinical practice.’
 

Media coverage